1 – 10 of 69
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia
2025) In Australian and New Zealand Journal of Psychiatry(
- Contribution to journal › Article
-
Mark
Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders : A systematic review and meta-analysis
(
- Contribution to journal › Article
-
Mark
Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia : A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC-FTD)
(
- Contribution to journal › Article
-
Mark
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
(
- Contribution to journal › Article
-
Mark
Biofluid biomarkers in distinguishing young-onset dementia from primary psychiatric disorders
(
- Contribution to journal › Scientific review
- 2024
-
Mark
Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light chain is increased in Niemann-Pick Type C but glial fibrillary acidic protein remains normal
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light chain is not elevated in people with first-episode psychosis or those at ultra-high risk for psychosis
(
- Contribution to journal › Article
-
Mark
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
(
- Contribution to journal › Article